These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 1398306)

  • 1. Recombinant erythropoietin for refractory anemia with ring sideroblasts.
    Musto P; Catalano L; Andriani A; Bodenizza C; Cascavilla N; Di Renzo N; Melillo L; Cicoira L; Carotenuto M; Rotoli B
    Haematologica; 1992; 77(2):185-6. PubMed ID: 1398306
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of anemia in myelodysplastic syndromes with recombinant human erythropoietin].
    Rodríguez JN; Prados D; Martino ML; Muñiz R
    Sangre (Barc); 1993 Aug; 38(4):340-1. PubMed ID: 8235952
    [No Abstract]   [Full Text] [Related]  

  • 3. [Neutropenia and hypotension during treatment with recombinant human erythropoietin in refractory anemia with ring sideroblasts].
    Benzadón RJ; Gurfinkel EP
    Sangre (Barc); 1990 Jun; 35(3):238-9. PubMed ID: 2396173
    [No Abstract]   [Full Text] [Related]  

  • 4. Current use of recombinant human erythropoietin (r-huEPO) in the management of symptomatic anaemia in patients with myelodysplastic syndromes (MDS).
    Marques da Costa R
    Sangre (Barc); 1994 Apr; 39(2):105-10. PubMed ID: 8059287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The concept of and countermeasures in refractory anemia].
    Yoshida Y
    Nihon Naika Gakkai Zasshi; 1990 May; 79(5):593-7. PubMed ID: 2199586
    [No Abstract]   [Full Text] [Related]  

  • 6. Refractory anemia with ringed sideroblasts (primary acquired sideroblastic anemia).
    Tomonaga M
    Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1419-27. PubMed ID: 2854694
    [No Abstract]   [Full Text] [Related]  

  • 7. Recombinant human erythropoietin (rHuEPO) for treatment of myelodysplastic syndrome.
    Zeigler ZR; Jones D; Rosenfeld CS; Shadduck RK
    Stem Cells; 1993 Jan; 11(1):49-55. PubMed ID: 8457781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of frataxin mutations in refractory anemia with ring sideroblasts (RARS).
    Gangat N; Porcher JC; Steensma DP
    Leuk Res; 2009 Apr; 33(4):586-7. PubMed ID: 18687468
    [No Abstract]   [Full Text] [Related]  

  • 9. Factors influencing nonleukemic death in refractory anemia, refractory anemia with ring sideroblasts, and refractory anemia with excess of blasts.
    Oguma S; Yoshida Y; Uchino H; Maekawa T
    Cancer Res; 1987 Jul; 47(13):3599-602. PubMed ID: 3581090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human erythropoietin for long-term persistent anemia after major ABO-incompatible bone marrow transplantation.
    Taniguchi S; Yamasaki K; Shibuya T; Asayama R; Harada M; Niho Y
    Bone Marrow Transplant; 1993 Oct; 12(4):423. PubMed ID: 8275046
    [No Abstract]   [Full Text] [Related]  

  • 11. Pressure sore anemia: response to erythropoietin.
    Turba RM; Lewis VL; Green D
    Arch Phys Med Rehabil; 1992 May; 73(5):498-500. PubMed ID: 1580782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life in end-stage renal disease patients during recombinant human erythropoietin therapy. The Canadian Erythropoietin Study Group.
    Keown PA
    Contrib Nephrol; 1991; 88():81-6; discussion 87-9. PubMed ID: 2040199
    [No Abstract]   [Full Text] [Related]  

  • 13. Best supportive care for the anaemia of myelodysplasia: inclusion of recombinant erythropoietin therapy?
    Bowen DT; Hellstrom-Lindberg E
    Leuk Res; 2001 Jan; 25(1):19-21. PubMed ID: 11137556
    [No Abstract]   [Full Text] [Related]  

  • 14. [The so-called refractory anemias].
    Frick P
    Schweiz Med Wochenschr; 1987 Sep; 117(36):1347-50. PubMed ID: 3116665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phase II clinical study of recombinant human erythropoietin on the anemia of myelodysplastic syndrome].
    Urabe A; Mizoguchi H; Takaku F; Miyazaki T; Yachi A; Niitsu Y; Miura Y; Mutoh Y; Fujioka S; Nomura T
    Rinsho Ketsueki; 1993 Aug; 34(8):928-36. PubMed ID: 8411647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The strategy for the treatment of myelodysplastic syndromes].
    Hideaki M
    Rinsho Ketsueki; 2002 Mar; 43(3):157-60. PubMed ID: 11979745
    [No Abstract]   [Full Text] [Related]  

  • 17. Human recombinant erythropoietin (rHuEPO) in the treatment of anemia in patients with chronic renal failure (CRF): experience with a group of patients on chronic haemodialysis treatment.
    Ramírez B; Flores A; Pérez F; Córdoba C; García L; Vázquez G
    Transplant Proc; 1991 Apr; 23(2):1833-4. PubMed ID: 2053170
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum erythropoietin levels in allogeneic, non T-depleted bone marrow transplantation, and the effects of rhEpo administration.
    Bosi A; Vannucchi AM; Grossi A; Guidi S; Rafanelli D; Saccardi R; Ferrini PR
    Bone Marrow Transplant; 1991; 7 Suppl 2():87. PubMed ID: 1878736
    [No Abstract]   [Full Text] [Related]  

  • 19. [RAEB with ringed sideroblasts in a 3-month-old boy].
    Nagasawa H; Kondou T; Yasuda K; Yamazaki Y; Nishida T; Yamada H
    Rinsho Ketsueki; 1987 Jul; 28(7):1181-6. PubMed ID: 3694825
    [No Abstract]   [Full Text] [Related]  

  • 20. Familial sideroblastic anemia with emergence of monosomy 5 and myelodysplastic syndrome.
    Kardos G; Veerman AJ; de Waal FC; van Oudheusden LJ; Slater R
    Med Pediatr Oncol; 1996 Jan; 26(1):54-6. PubMed ID: 7494512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.